Figure 1.
Phase III IMpower trials for first-line treatment of non-Sq NSCLC. Bev, bevacizumab; CBDCA, carboplatin; CDDP, cisplatin; NSCLC, non-small cell lung cancer; PEM, pemetrexed; PTX, paclitaxel; R, randomized study; Sq, squamous.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.